Waterloo Capital, L.P.
Source: SEC Form 13F · as of Mar 2026Waterloo Capital, L.P. holds 22 biotech & pharma companies tracked by BioSniper, totaling $38.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$38.5M
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 41,374 | $6.8M |
| JNJJOHNSON & JOHNSON | 23,463 | $5.7M |
| DGXQuest Diagnostics Incorporated | 24,819 | $4.9M |
| ABBVAbbVie Inc. | 21,054 | $4.6M |
| LLYELI LILLY & Co | 3,663 | $3.4M |
| MRKMerck & Co., Inc. | 27,070 | $3.3M |
| CORCencora Inc. | 5,173 | $1.6M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 3,068 | $1.4M |
| PFEPFIZER INC | 34,043 | $956K |
| ABTABBOTT LABORATORIES | 6,268 | $644K |
| CAHCardinal Health Inc. | 2,971 | $628K |
| GMOptec International, Inc. | 8,275 | $616K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,266 | $613K |
| BMYBRISTOL MYERS SQUIBB CO | 9,966 | $604K |
| GILDGILEAD SCIENCES, INC. | 3,823 | $533K |
| AMGNAMGEN INC | 1,188 | $418K |
| WSTWest Pharmaceutical Services Inc. | 1,657 | $415K |
| UTHRUNITED THERAPEUTICS Corp | 570 | $338K |
| REGNREGENERON PHARMACEUTICALS, INC. | 401 | $310K |
| INCYIncyte Corp. | 3,230 | $304K |
| MCKMcKesson Corporation | 262 | $227K |
| IDXXIDEXX LABORATORIES INC /DE | 392 | $220K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.